Company Profile
SYN-TECH CHEM. & PHARM. CO., LTD. was established in 1982 as an invested enterprise of Standard Chem. & Pharm. Co., Ltd., and successfully listed on the Taiwan Over-the-Counter (OTC) market in 2005.
The company specializes in the research, development, manufacturing, and sales of high-quality products, with a product portfolio covering:
- Active Pharmaceutical Ingredients (APIs) for Human Use
- Pharmaceutical Excipients
Our products are distributed across:
Europe | Americas | Asia | Africa | Australia | Taiwan
The company adheres to the business philosophy of "Integrity, Pragmatism, Innovation, and Development". From the R&D stage, we follow strict operational standards and fully implement quality management systems to ensure all products comply with PIC/S GMP standards.
Company Introduction
Discover SYN-TECH's commitment to pharmaceutical excellence through our comprehensive English introduction, showcasing our advanced manufacturing capabilities and international quality standards.
公司介紹影片
In-depth understanding of SYN-TECH's corporate culture, production technology, and quality management through our detailed Chinese introduction, showcasing our professional expertise in API manufacturing.
Quality Certifications
Since its inception, SYN-TECH has passed rigorous inspections and received certifications from regulatory authorities and leading pharmaceutical companies worldwide:
SYN-TECH has also achieved the following management system certifications through AFNOR Asia, ensuring the highest standards of product quality, environmental stewardship, and occupational safety:
All ISO certifications are issued and audited by AFNOR Asia.
International Partners
Technical Expertise
Leveraging advanced organic synthesis technology as its core competency, SYN-TECH has successfully developed and manufactured over 100 types of APIs across various therapeutic areas including local anesthetics, cardiovascular drugs, urological agents, and topical medications. Our products are widely adopted by major pharmaceutical manufacturers both domestically and internationally. The company is dedicated to the development of new products, pharmaceutical intermediates, and optically active chemicals, while conducting polymorphic studies to enhance product technology and competitiveness. Additionally, we actively develop asymmetric reduction technologies for application in optically active products and new compound processes, advancing our capabilities in new drug development.
Quality Policy
SYN-TECH places great emphasis on quality and safety. Our facilities are well-organized with systematic equipment layout, implementing automated inspection and operation management along with regular training programs to ensure our quality policy of "Quality Assurance, Safety First." The company will continue to dedicate itself to new product development and product internationalization, striving to deliver reliable, high-quality APIs that meet the evolving needs of global pharmaceutical manufacturers.